3-phosphoinositide-dependent kinase-1 inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name3-phosphoinositide-dependent kinase-1 inhibitors (Pfizer)
Drug Alias NamePF-5177624PF-05177624PF-05197281
ClassificationSmall molecules
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitorsAnticancer protein kinase inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A